Spain Speeds Up Negotiations on Vaccine Procurement to Save Lives, and Countries will Compensate for Adverse Reactions After Vaccination

Spain is currently in procurement negotiations with a number of international laboratories and will assume compensation for possible adverse reactions. If someone has an adverse reaction due to the coronavirus vaccine, it is the Spanish Ministry of Health that makes the compensation.

According to 'La Razon Daily', it is a foreseeable and will happen fact that some people are vaccinated with the COVID-19 vaccine causing adverse consequences. At present, when governments are negotiating with various laboratories around the world, compensation is one of the conditions. Although compensation will be extended to all countries like a domino effect, the compensation schemes of each country may be different. Spain is handed over to the Administration of Drug Safety under the Ministry of Health, that is, once someone has an adverse reaction after vaccination, the compensation is Spanish Ministry of Health.

La Razon Daily stated that the Spanish government is exploring multiple vaccine distribution plans in negotiations with multiple laboratories. Some are vaccine supply cases during the peaceful period (that is, when there is no epidemic). At this time, the vaccine must be much safer and more reliable and the price is also higher. This plan is that once there is an adverse reaction, it is the laboratory that compensates.

But under the current circumstances, what Spain needs more is the 'pandemic supply case', which is the urgently needed program under the current epidemic. This program will speed up various processes after the vaccine is approved for use, and distribute the vaccine as soon as possible for the purpose of saving lives. , But the risk of adverse reactions is greater. Therefore, in this case, the laboratory will push the compensation promise to the government, because this is an urgent need program under the urging of the government. This is a condition required by many international vaccine research and development companies. The case cited also points out that the United States also adopts this scheme, that is, the state bears compensation.